Neoadjuvant immune-checkpoint blockade in resectable colon cancer

被引：0
作者：
George Coukos
机构：
[1] University of Lausanne and University Hospital of Lausanne,Ludwig Institute for Cancer Research, and Department of Oncology
来源：
Nature Medicine | 2020年 / 26卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
Neoadjuvant checkpoint blockade achieves deep or complete pathologic responses in patients with mismatch-repair-deficient and mismatch-repair-proficient early colon cancer.
引用
收藏
页码：473 / 474
页数：1
相关论文
共 13 条
[1]  
Le DT(2015)undefined N. Engl. J. Med. 372 2509-2520
[2]  
Wei SC(2018)undefined Cancer Discov. 8 1069-1086
[3]  
Duffy CR(2014)undefined Nature 515 568-571
[4]  
Allison JP(2018)undefined Nat. Med. 24 994-1004
[5]  
Tumeh PC(2020)undefined Nat. Med. 26 193-199
[6]  
Thommen DS(2019)undefined Nat. Med. 25 1251-1259
[7]  
Fairfax BP(2019)undefined Immunity 50 195-211.e10
[8]  
Yost KE(2017)undefined Nature 551 517-520
[9]  
Siddiqui I(2016)undefined Cancer Discov. 6 1382-1399
[10]  
Łuksza M(2019)undefined Immunity 50 477-492.e8
12